EBJIS假体周围感染DAIR推荐的外部验证:英国专科与非专科医院研究
本研究为多中心回顾性队列,纳入英国七家医院411例髋或膝关节假体周围感染接受DAIR的成人患者,按EBJIS推荐分组并分析手术技术。中位随访2.1年,失败率47.0%;DAIR不推荐组失败风险显著高于推荐组(HR 1.64),未更换组件与失败强相关(HR 2.40)。
要点
- EBJIS推荐分组与DAIR失败风险相关,不推荐组风险显著升高。
- DAIR未更换组件与治疗失败强相关,风险比为2.40。
- 最有利情景成功率78.8%,最不利情景仅28.0%。
核心结论
- EBJIS患者选择与手术技术均与DAIR后结局相关,未更换组件与失败关联最强。
- EBJIS框架在专科与非专科中心具有实用性和可推广性。
研究设计与样本
- 多中心回顾性队列研究,涉及英国七家医院,纳入411例髋或膝关节PJI接受DAIR的成人患者。
主要发现
- 411例中DAIR推荐组82例(20.0%),风险因素组103例(25.1%),不推荐组226例(55.0%)。
- 中位随访2.1年(IQR 0.58至5.5),193例(47.0%)治疗失败。
- 与推荐组相比,不推荐组失败风险显著更高(HR 1.64,95%CI 1.14至2.35;p=0.007),风险因素组无显著差异(HR 1.14,95%CI 0.60至2.15;p=0.689)。
- 未更换组件与失败强相关(HR 2.40,95%CI 1.89至3.06;p<0.001)。
- 最有利情景(推荐且更换组件)成功率78.8%(26/33),最不利情景(不推荐且未更换)成功率28.0%(26/93)。
关键数值与推荐
- EBJIS推荐将患者分为DAIR推荐、风险因素和不推荐三类,手术技术分为更换组件与不更换组件。
- 主要终点为因感染需再次手术、长期抑制性抗生素、90天内死亡、截肢或关节融合。
临床怎么用
- EBJIS框架可用于DAIR患者选择和手术标准化,支持共享决策。
- 临床应重视DAIR中更换组件,未更换组件与失败风险显著升高相关。
局限性
- 回顾性队列设计可能引入偏倚,结论需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to externally validate the European Bone & Joint Infection Society (EBJIS) recommendations for the use of debridement, antibiotics, and implant retention (DAIR) in the treatment of periprosthetic joint infection (PJI), examining the independent associations of the selection of patients and the operative technique with failure after DAIR. METHODS: This was a multicentre retrospective cohort study involving seven UK hospitals and including adults with hip or knee PJI treated with DAIR. Patients were classified by EBJIS recommendations (DAIR-indicated, risk factors, or not recommended) and operative technique (exchange of components vs no exchange). The primary endpoint was the failure of treatment as defined by the need for further surgery for infection, long-term suppressive antibiotics, or death within 90 days, amputation, or arthrodesis. Sensitivity analyses were stratified by joint and repeated, excluding long-term suppressive antibiotics from the composite endpoint. RESULTS: A total of 411 patients (165 hips; 246 knees) were analyzed: 82 (20.0%) DAIR-indicated, 103 (25.1%) with risk factors, and 226 (55.0%) not recommended. Modular components were exchanged in 213 (51.8%). Over a median 2.1 years of follow-up (IQR 0.58 to 5.5), failure occurred in 193 patients (47.0%). Compared with the DAIR-indicated group, the DAIR not recommended group had a significantly higher risk of failure (hazard ratio (HR) 1.64 (95% CI 1.14 to 2.35); p = 0.007), whereas the risk factor group had a similar risk (HR 1.14 (95% CI 0.60 to 2.15); p = 0.689). DAIR without exchange of components was strongly significantly associated with failure of treatment (HR 2.40 (95% CI 1.89 to 3.06); p < 0.001). Joint-stratified and sensitivity analyses showed a similar direction of effect. Treatment was successful in 78.8% (26/33) in the most favourable scenario (DAIR-indicated with exchange of components) compared with 28.0% (26/93) in the least favourable scenario (DAIR not recommended without exchange of components). CONCLUSION: In this external validation, both EBJIS patient selection and operative technique were associated with the outcomes after DAIR, with lack of exchange of components showing the strongest association with failure of treatment. The EBJIS framework is pragmatic and generalizable across specialist and non-specialist centres, and can support shared decision-making and the standardization of surgery in these patients.
引用
- Hotchen AJ, Richards J, Thumbadoo RP, et al. Validation of the European Bone & Joint Infection Society recommendations for debridement, antibiotics, and implant retention in hip and knee periprosthetic joint infection : a study from specialist and non-specialist hospitals in the UK. Bone Joint J. 2026. PMID: 42853098. doi:10.1302/0301-620X.108B10.BJJ-2026-0028.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。